Almost 2 Years Ago
1 Min Read
MYMD jumping 23% today. Here's what's moving the stock:
MyMD Pharmaceuticals Inc (MYMD) is trading 23% higher at $5.71 today.
- Presenting at the Dawson James Securities 6th Annual Small Cap Growth Conference on October 21
- Strong track record of success in developing new therapies for diseases such as cancer and Alzheimer's disease
MyMD Pharmaceuticals Inc has been trading between a 52-week high of $9.95 and a 52-week low of $1.88. The stock has a market cap of $217 Million.
MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-α, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines.
MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-α, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines.
Headlines
MyMD Pharmaceuticals to Discuss its Novel Therapies for Aging and Related Diseases at the Dawson James Securities 6th Annual Small Cap Growth Conference on October 21
Kwhen Finance 10-19-21
Recommended Articles
